Metabolically healthy obesity: different prevalences using different criteria (Q42971241)

12 November 2017

Metabolically healthy obesity: different prevalences using different criteria (English)

1 reference

12 November 2017

0 references

5

1 reference

12 November 2017

S Velho

1

1 reference

12 November 2017

F Paccaud

series ordinal

2

1 reference

12 November 2017

G Waeber

series ordinal

3

1 reference

12 November 2017

P Vollenweider

series ordinal

4

1 reference

12 November 2017

14 July 2010

1 reference

European Journal of Clinical Nutrition

12 November 2017

1 reference

12 November 2017

64

1 reference

12 November 2017

1043-1051

1 reference

12 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2010.114

12 November 2017

0 references

cites work

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Universal cut-off BMI points for obesity are not appropriate

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Body composition at the bedside.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Waist circumference and not body mass index explains obesity-related health risk

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Metabolically healthy but obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Can we identify metabolically healthy but obese individuals (MHO)?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

The metabolically healthy but obese individual presents a favorable inflammation profile

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Global burden of obesity in 2005 and projections to 2030.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Waist circumference as a measure for indicating need for weight management.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Are natural killer cells protecting the metabolically healthy obese patient?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Prevalence of obesity and abdominal obesity in the Lausanne population

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Cardiovascular risk factors and alcohol consumption in France and Northern Ireland

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Prevalence of normal weight obesity in Switzerland: effect of various definitions.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Identifying metabolically healthy but obese individuals in sedentary postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Validity of a self-reported measure of familial history of obesity

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Acquired preference especially for dietary fat and obesity: a study of weight-discordant monozygotic twin pairs

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Obesity, insulin resistance and diabetes — a worldwide epidemic

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Body water compartment measurements: A comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniques

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Systemic effects of smoking

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.114

7 January 2021

Identifiers

DOI

10.1038/EJCN.2010.114

1 reference

Dimensions Publication ID

12 November 2017

0 references

1 reference